Search
Search Results
##search.searchResults.foundPlural##
-
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6440PDF: 2179HTML: 14139Untitled: 213figure: 199 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7940PDF: 747HTML: 253 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3267PDF: 1886HTML: 3683 -
-
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
2415PDF: 985HTML: 11149 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4156PDF: 1277HTML: 2112Table 1: 212 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2546PDF: 1347HTML: 1809CoverLetter: 196 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1455PDF: 848HTML: 8671Fig 3 Savini: 186Fig 2 Savini: 194Fig 1 Savini Chest TC: 197Author letter to referees: 200 -
THE HEMATOLOGICAL PARAMETERS AND BIOCHEMICAL MARKERS OF IRON STATUS IN ALFA-THALASSEMIA 3.7KB DELETION FROM METROPOLITAN REGION OF MANAUS, AMAZONAS, BRAZIL. alfa-Thalassemia 3.7 deletion From Amazonas, Brazil.
4217PDF: 642HTML: 450 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3402PDF: 1357HTML: 6337 -
SPHINGOMONAS PAUCIMOBILIS INFECTIONS IN CHILDREN: NOSOCOMIAL VERSUS COMMUNITY ACQUIRED INFECTIONS
1835PDF: 1044HTML: 2077cover: 190Table 1. Co-morbidities associated with Sphingomonas paucimobilis infections.: 196Figure 1. The antimicrobial susceptibility patterns of Sphingomonas paucimobilis isolated from clinical specimens: 1690title page: 199 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1579PDF: 1124HTML: 259 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2313PDF: 1007HTML: 4972 -
WHAT ARE FUNGAL INFECTIONS?
4300PDF: 2453HTML: 27657de Pauw: 257 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3485PDF: 1394HTML: 2712 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1873PDF: 934HTML: 1018Referring article: 769 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1130PDF: 799HTML: 149 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3812PDF: 1455HTML: 3855Letter to Editor: 204 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3304PDF: 1048HTML: 2280 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3834PDF: 1328HTML: 853Figure 2: 474Figure 1: 3154 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1799PDF: 1134HTML: 10746Untitled: 203 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2017PDF: 838HTML: 2211Table 1: 195Table 2: 213Table 3: 208Table 4: 209Table 5: 209Tble 6: 201Cover Letter: 220Greene Tab.7: 216
1 - 45 of 45 items







